期刊文献+

霍乱疫苗中残余霍乱毒素检测方法的建立及验证

The establishment and validation of method for detecting residual cholera toxin in cholera vaccine
下载PDF
导出
摘要 采用间接酶联免疫法,即用神经节苷脂包被,加入待检样品,再加入兔抗霍乱毒素B亚单位抗体,用标准样品的吸光值(A值)对标准样品的浓度绘制4-参数拟合曲线,根据标准曲线计算出待测样品中的CT浓度。结果显示,在浓度范围(0.6~16)ng/ml之间,CT标准浓度和检测浓度成线性关系,r2=0.9986。精确度在浓度范围(0.6~16)ng/ml,CT的平均回收率在96.24%~114.44%之间。精密度:批内变异CV%≤12.98%,批间变异CV%≤18.48%。特异性CT浓度在10ng/ml时,平均回收率为102.6%;CT浓度在5ng/ml时,平均回收率为111.17%;CT浓度在2.5ng/ml时,平均回收率为123.83%。实验表明该方法可检测霍乱疫苗原液中CT的含量。 To establish a method for detecting residual cholera toxin in cholera vaccine.By using a indirect enzyme-linked immunosorbent assay,briefly,the samples were added to microtiter plates previously coated with ganglioside GM1,then the rabbit anti-cholera toxin B subunit antibody was added.4-parameter fitting curve was plotted against the absorbance values(A)and the concentration of standard samples.CT concentrations in the tested samples were calculated according to the standard curve.The results showed that when the concentration is(0.6 - 16)ng/ml,CT standard concentration and the detected concentration has a linear relationship,r2=0.9986.Degree of accuracy: when the concentration is(0.6 - 16)ng/ml,the average recovery rate can reach 96.24% - 114.44%.Degree of precision: the CV of within group≤12.98%,the CV between groups≤18.48%.Specificity: when the concentration of CT is 10ng/ml,5ng/ml and 2.5ng/ml,the average recovery rate is 102.6%,111.17% and 123.83% separately.This method can be used to detect the CT concentration in cholera liquid vaccine.
出处 《微生物学免疫学进展》 2011年第1期32-36,共5页 Progress In Microbiology and Immunology
基金 "艾滋病和病毒性肝炎等重大传染病防治"科技重大专项项目子课题之一
关键词 霍乱毒素 间接酶联免疫法 神经节苷脂 Cholera toxin Indirect enzyme-linked immunosorbent assay Ganglioside
  • 相关文献

参考文献7

  • 1Svennerholm AM,Wiklund G.Rapid GM1-Enzyme-linked immu-nosorbent assay with visual reading for identification of Eschertchlacoli heat-labile enterotoxin. Journal of Clinical Microbiology . 1983
  • 2Svennerholm AM,Holmgren J,BlackB,et al.Serologic differen-tiation between antitoxin responses to infection with Vibrio choleraeand enterotoxin producing Eccherichia coli. The Journal of Infectious Diseases . 1983
  • 3Trach DD,Cam PD,Ke NT,et al.Investigations into the safety andimmuno-genicity of a killed oral cholera vaccine developed in VietNam. Bulletin of the World Health Organization . 2002
  • 4Czerkinsky C,Moldoveanu Z,Mestecky J,et al.A novel two colour ELISPOT assay.Ⅰ.Simultaneous detection of distinct types of antibody-secreting cells. Journal of Immunological Methods . 1988
  • 5Anh DD,Canh do G,Lopez AL,et al.Safety and immunogenicity of a reformulated Vietnamese bivalent killed,whole-cell,oral cholera vaccine in adults. Vaccine . 2007
  • 6Vu Dinh Thiem Jacqueline L. Deen Lorenz von Seidlein Do Gia Canh Dang Duc Anh Jin-Kyung Park Mohammad Ali M. Carolina Danovaro-Holliday.Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine . 2006
  • 7Mahalanabis,D,A.L.Lopez,et al."A randomized,placebo-controlled trial of the bivalent killed,whole-cell,oral cholera vaccine in adults and children in a cholera endemic area in Kolkata,India.". PLoSOne . 2008

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部